MediGene AG

  • Market Cap: Micro Cap
  • Industry: Biotechnology
  • ISIN: DE000A1X3W00
EUR
0.13
-0.05 (-27.64%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

189.47 k

Shareholding (Mar 2018)

FII

0.17%

Held by 1 FIIs

DII

99.83%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Biotechnology

stock-summary
Market cap

EUR 35 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.75

stock-summary
Return on Equity

-94.75%

stock-summary
Price to Book

1.68

Revenue and Profits:
Net Sales:
4 Million
(Quarterly Results - Dec 2019)
Net Profit:
0 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-92.58%
0%
-92.58%
6 Months
-91.93%
0%
-91.93%
1 Year
-95.36%
0%
-95.36%
2 Years
-92.64%
0%
-92.64%
3 Years
-97.65%
0%
-97.65%
4 Years
-98.32%
0%
-98.32%
5 Years
-98.4%
0%
-98.4%

MediGene AG for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
15.11%
EBIT Growth (5y)
-36.99%
EBIT to Interest (avg)
-14.36
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.75
Sales to Capital Employed (avg)
0.26
Tax Ratio
0.22%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.17%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.68
EV to EBIT
-0.97
EV to EBITDA
-0.97
EV to Capital Employed
3.70
EV to Sales
1.87
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-382.25%
ROE (Latest)
-94.75%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2018stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.17%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'19 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2019 is 125.00% vs -36.00% in Dec 2018",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2019 is 100.00% vs -68.97% in Dec 2018",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'19",
        "Dec'18",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3.60",
          "val2": "1.60",
          "chgp": "125.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.10",
          "val2": "-4.10",
          "chgp": "102.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.00",
          "val2": "-4.90",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "40.60%",
          "val2": "-2,600.30%",
          "chgp": "264.09%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is -80.77% vs 197.14% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is -95.18% vs 17.00% in Dec 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6.00",
          "val2": "31.20",
          "chgp": "-80.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-15.00",
          "val2": "12.70",
          "chgp": "-218.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.50",
          "val2": "0.60",
          "chgp": "-16.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-16.20",
          "val2": "-8.30",
          "chgp": "-95.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,732.80%",
          "val2": "-291.90%",
          "chgp": "-244.09%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'19 - YoYstock-summary
Dec'19
Dec'18
Change(%)
Net Sales
3.60
1.60
125.00%
Operating Profit (PBDIT) excl Other Income
0.10
-4.10
102.44%
Interest
0.10
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.00
-4.90
100.00%
Operating Profit Margin (Excl OI)
40.60%
-2,600.30%
264.09%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2019 is 125.00% vs -36.00% in Dec 2018

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2019 is 100.00% vs -68.97% in Dec 2018

Annual Results Snapshot (Consolidated) - Dec'23stock-summary
Dec'23
Dec'22
Change(%)
Net Sales
6.00
31.20
-80.77%
Operating Profit (PBDIT) excl Other Income
-15.00
12.70
-218.11%
Interest
0.50
0.60
-16.67%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-16.20
-8.30
-95.18%
Operating Profit Margin (Excl OI)
-2,732.80%
-291.90%
-244.09%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is -80.77% vs 197.14% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is -95.18% vs 17.00% in Dec 2022

stock-summaryCompany CV
About MediGene AG stock-summary
stock-summary
MediGene AG
Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available